SEC/VC  Revelation Partners

https://revelation-partners.com/





     Office Locations:

300 Turney Street
Sausalito, CA 94965
Phone: 415-636-5420

 
Stages:

  • Expansion


 
Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  
    Description:

    Revelation Partners is the largest secondaries investment manager providing flexible capital solutions exclusively to the private healthcare ecosystem. Headquartered in Sausalito, Calif., Revelation Partners has $1.5 billion of committed capital and invests broadly across all healthcare sub-sectors. The firm offers tailored solutions for shareholders seeking liquidity and companies that need growth capital. With decades of investing experience, deep sector expertise, and an extensive industry network, Revelation Partners is a trusted partner to healthcare investors, companies, founders, and funds. Revelation invests in late-stage, private companies across healthcare sectors, including medical devices, biopharmaceuticals, healthcare technology and services, and life science tools and diagnostics. If commercial scale, companies typically have at least $20 million of revenue.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     
    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Andrew Olson Partner, CFO, COO
    Doug Fisher Partner
    Eric Shiozaki Partner
    Fred Lee Partner
    Liz Staley Partner & Chief Compliance Officer

     
    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      11/20/2025


      Aspen Neuroscience


      CA


      $115,000,000


      Series C


      03/31/2025


      Arbor Biotechnologies


      MA


      $73,900,000


      Series C


      02/20/2025


      VitalConnect


      CA


      $100,000,000


      Debt and Equity Financing


     
    Portfolio companies include:

     
    Recent News: